Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLa80 probiotic powder for acute watery diarrhea in young children
ChiCTR2100053699Phase 4Completed
- Sponsor
- Chengdu Women's and Children's Central Hospital
- Start
- Nov 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bifidobacterium animalis subsp. lactis BLa80 in acute watery diarrhea (2 arms), sponsored by Chengdu Women's and Children's Central Hospital. Primary endpoints: Number of diarrhea episodes and Stool property. Started Nov 2021; status: completed.
02
Drugs
bifidobacterium animalis subsp. lactis BLa80
03
Conditions
acute watery diarrhea
Beyond the preview
Go deeper on ChiCTR2100053699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053699.